| |
Recent advances in nanomaterials indicates that the
central nervous system (CNS) is susceptible to nanoparticle induced
alterations leading to functional or structural alterations. This
knowledge is currently disseminated in vast array of journals dealing
with broad subject areas related to pharmacology, toxicology,
neuroscience or nanosciences. Thus, there is an urgent need to collect
all these diverse information related to nanoscience and brain function
in one place using Journal of Nanoneuroscience for the
benefit of the scientific community, researchers, health planners,
health care providers, policy makers, environmentalists, biologists,
chemists, and physicist in this emerging area of medical science. Journal
of Nanoneuroscience will publish peer-reviewed original articles,
reviews, commentary on the state of the art knowledge in any field
mentioned above, brief communication, letters and comments on the
articles published in the journal. To speed up the reviewing process, we
will provide on-line refereeing of all articles submitted in electronic
form. Authors will receive the following benefits: |
| |
Journal of Nanoneuroscience deals with all
branches of neurosciences, medicine and biology including
neurochemistry, neurobiology, neurogenetics, neurophysiology,
neuropathology, neuropharmacology, neuroprotection, neuroregeneration,
neuroimmunology, neurosurgery, neuroanatomy, neurology, neuropsychiatry,
neurorehabilitation, neurotrauma, neurooncology, neuroradiology,
neuroepidemiology, neuroendocrinology, neurocytology, developmental
neuroscience, cognitive neuroscience, neurotransmitters, molecular and
cellular neuroscience, neuroelectronics, neural engineering,
neurosensors, neuropharmaceutics, drug design and drug discovery,
drug/alcohol effects, environment and health effects, computational and
theoretical neuroscience, biotechnology, biomedicine and other research
topics related to nanoscale neuroscience, regenerative medicine,
nanotoxicology, diagnosis, therapy, prevention, treatment of all types
of diseases, nanoscale drugs and delivery systems, nanoscale drug
delivery systems including solid lipid nanoparticles, liposomes,
polysaccharides, polyesters, micelles, different route-based delivery
systems such as oral, pulmonary, ocular, and dermal, stem cells in
cancer treatment, immunotherapy, biological markers, molecular imaging,
gene delivery, interactions of nanobiomaterials with cells, tissues, and
organs; biological macromolecules such as proteins, peptides, nucleic
acids, DNA-based self-assemblies, biomolecules, cells, biochips,
biocompatibility aspects of nanomaterials, drug and protein delivery,
BioNEMS/MEMS, nanoscale physiology and pathology, nanoscale proteomics,
nanoscale cellular and tissue engineering, biomimetics, biosensors,
bioinformatics, theoretical and computational aspects of nanomedicine.
|
